Literature DB >> 8333874

Models for the A- and B-receptor-bound conformations of CCK-8.

G V Nikiforovich1, V J Hruby.   

Abstract

Energy calculations were performed for CCK-8 (Asp26-Tyr(SO3)27-Met28-Gly29- Trp30-Met31-Asp32-Phe33-NH2, I) and [desaminoTyr(SO3)27, Nle28,31]CCK-7 (II), which are nonselective ligands of CCK receptors, and for the CCK-A selective analog [desaminoTyr(SO3)27, Nle28,31, N-Me-Asp32]CCK-7 (III) and the CCK-B selective analog [desaminoTyr(SO3)27, Nle28, N-Me-Leu31]CCK-7 (IV). The geometrical shapes of the obtained low energy backbone conformers were then compared with each other, searching for similar spatial arrangements of specific atomic centers. The comparisons were performed separately for peptides with high affinity towards CCK receptors of the A type (compounds I, II and III) and for peptides with high affinity towards CCK receptors of the B type (compounds I, II and IV). Possible models for CCK "A"- and "B"-receptor-bound conformations were then developed. The proposed CCK "B-conformation" has a distorted beta-III turn at the C-terminal Gly-Trp-Met-Asp fragment, the Phe33 residue and the C-terminal amide being directed outward from the turn. The CCK "A-conformation" has two reversals of the peptide chain so that the C alpha-atoms of the C-terminal pentapeptide appear at the corners of a nearly regular pentagon, and a distinct beta-II turn is centered at the N-terminal Tyr-Met-Gly-Trp fragment, the planes of the turn and the pentagon being almost perpendicular. The proposed models are consistent with the results of biological testing for CCK related peptides including cyclic analogs and CCK-A selective tetrapeptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333874     DOI: 10.1006/bbrc.1993.1777

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain.

Authors:  V J Hruby; R S Agnes; P Davis; S-W Ma; Y S Lee; T W Vanderah; J Lai; F Porreca
Journal:  Life Sci       Date:  2003-06-27       Impact factor: 5.037

2.  Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.

Authors:  Richard S Agnes; Yeon Sun Lee; Peg Davis; Shou-Wu Ma; Hamid Badghisi; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2006-05-18       Impact factor: 7.446

3.  Structure-activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.

Authors:  Richard S Agnes; Jinfa Ying; Katalin E Kövér; Yeon Sun Lee; Peg Davis; Shou-wu Ma; Hamid Badghisi; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Peptides       Date:  2008-04-10       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.